Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 81-90 of 95 for transplant

  • Results filtered:
  • Study status: Open/Status Unknown
Edit search filters
  1. Testing Whether High Dose Chemotherapy And Infusion Of The Patients' Own Stem Cells Improves Survival In Patients With Peripheral T-cell Lymphoma Who Achieved A Complete Response At The End Of The Initial Chemotherapy

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  2. Assessing the Psychosocial and Financial Impact of CAR-T on Survivors and Caregivers

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  3. A Study Of DdcfDNA For Kidney Transplant Monitoring

    Jacksonville, FL

  4. A Study Of How Transplant Centers Are Supporting Patients With Undocumented Or Uncertain Immigration Status

    Jacksonville, FL

  5. A Study Of Free Tacrolimus Level In Solid Organ Transplant Recipients

    Rochester, MN

  6. Liver Kinase B1 and Interstitial Fibrosis and Tubular Atrophy and Kidney Transplant Recipients

    Scottsdale/Phoenix, AZ

  7. Fractionated Anti HLA Antibodies Role in Prevention of Sold Organ Transplant Rejection

    Jacksonville, FL

  8. Authorizaton to Use Clincially Obtained Data for Research

    Rochester, MN

  9. A Study Of Biomarkers To Optimize Immunosuppression Late Post-Liver Transplant

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  10. Characterizing Treg and T Cell Subsets in Liver Transplant Recipients With Operational Tolerance.

    Scottsdale/Phoenix, AZ

.

Mayo Clinic Footer